Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Curosurf
Active Ingredient: Poractant Alfa 80mg/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Chiesi Farmaceutici S.p.A., Parma, Italy
Dated this 6th day of September 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).